Wechsler Daniel Mark 4
4 · MELINTA THERAPEUTICS, INC. /NEW/ · Filed May 31, 2018
Insider Transaction Report
Form 4
Wechsler Daniel Mark
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2018-05-29$5.00/sh+50,000$250,000→ 50,000 total
Footnotes (1)
- [F1]These shares were purchased from the underwriters pursuant to an underwritten public offering by the Issuer. The offering closed on May 29, 2018.